Eduardo Gutiérrez-León

Eduardo Gutiérrez-León

Auto-generated profile, based on publicly available information

Eduardo Gutiérrez-León

Faculty of Medicine, Universidad Nacional Autónoma de México, Circuito de Posgrados s/n, Ciudad Universitaria, Coyoacán, Mexico City 04510, Mexico; Departamento de Hematología y Oncología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Secc. 16, Tlalpan, Mexico City 14080, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
Marcela Rodríguez-FloresMarcela Rodríguez-Flores
Marcela Rodríguez-Flores
EGEduardo W. Goicochea-Turcott
Eduardo W. Goicochea-Turcott
LMLeonardo Mancillas-Adame
Leonardo Mancillas-Adame
NGNayely Garibay-Nieto
Nayely Garibay-Nieto
MLMalaquías López-Cervantes
Malaquías López-Cervantes
EGEdward W. Gregg
Edward W. Gregg
Background: Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of the Edmonton Obesity Staging System (EOSS), a clinical classification tool that assesses obesity-related comorbidity, is compared with BMI, with respect to adverse COVID-19 outcomes. Methods: 1071 patients were evaluated in 11 COVID-19 hospitals in Mexico. Patients were classified into EOSS stages. Adjusted risk factors for COVID-19 outcomes were calculated and survival analysis for mechanical ventilation and death was carried out according to EOSS stage and BMI category. Results: The risk for intubation was higher in patients with EOSS stages 2 and 4 (HR 1.42, 95% CI 1.02–1.97 and 2.78, 95% CI 1.83–4.24), and in patients with BMI classes II and III (HR 1.71, 95% CI 1.06–2.74, and 2.62, 95% CI 1.65–4.17). Mortality rates were significantly lower in patients with EOSS stages 0 and 1 (HR 0.62, 95% CI 0.42–0.92) and higher in patients with BMI class III (HR 1.58, 95% CI 1.03–2.42). In patients with a BMI ≥ 25 kg/m2, the risk for intubation increased with progressive EOSS stages. Only individuals in BMI class III showed an increased risk for intubation (HR 2.24, 95% CI 1.50–3.34). Mortality risk was increased in EOSS stages 2 and 4 compared to EOSS 0 and 1, and in patients with BMI class II and III, compared to patients with overweight. Conclusions: EOSS was associated with adverse COVID-19 outcomes, and it distinguished risks beyond BMI. Patients with overweight and obesity in EOSS stages 0 and 1 had a lower risk than patients with normal weight. BMI does not adequately reflect adipose tissue-associated disease, it is not ideal for guiding chronic-disease management.

9 May 2026 in Journal of Cancer Policy
Verified
Journal Article
Open access
JHJorge H. Hernandez-Felix
Jorge H. Hernandez-Felix
EGEduardo Gutierrez-Leon
Eduardo Gutierrez-Leon
YCYanin Chavarri-Guerra
Yanin Chavarri-Guerra
FHFidel David Huitzil-Melendez
Fidel David Huitzil-Melendez
MMMonica Isabel Meneses-Medina
Monica Isabel Meneses-Medina
Cancer awareness months aim to convert public attention into health-seeking behavior and earlier diagnosis, but whether this occurs in Mexico remains unclear. We evaluated whether awareness months in Mexico were associated with increased online search interest and whether Breast Cancer Awareness Month (October) was associated with short-term changes in breast cancer notifications in the national surveillance system. We analyzed Google Trends monthly Search Volume Index (SVI) for breast, prostate, and colorectal cancers in Mexico (2010-2019). Interrupted time-series models estimated level changes during campaign months. For breast cancer, SVI was linked to monthly SUIVE incident counts using Welch's t-tests, seasonality-adjusted interrupted time series, and transfer-function models with lags of 0-3 months. Awareness months were consistently associated with recurrent SVI spikes: October for breast cancer (+30.98 SVI points, 95% CI 29.58-32.38), November for prostate (+21.62, 95% CI 16.99-26.23), and March for colorectal (+4.58, 95% CI -2.45 to +11.61; p = 0.201). Breast cancer incident reports increased over the decade but showed no significant contemporaneous or short-lag increase in October; associations between search interest and reported cases were small and inconsistent. In Mexico, cancer awareness months reliably mobilize digital attention but do not translate into near-term increases in breast cancer notifications. These findings indicate a mismatch between campaign-related attention and one downstream surveillance metric. Awareness months generate digital attention, but this attention did not translate into short-term increases in breast cancer reporting. Monthly operational indicators and strengthened diagnostic pathways are needed to turn attention into timely evaluation and earlier diagnosis.

29 April 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JRJuan José Rodríguez-Crespo
Juan José Rodríguez-Crespo
EGEduardo Gutiérrez-León
Eduardo Gutiérrez-León
PDPedro Dammann-Beltrán
Pedro Dammann-Beltrán
JSJurhiat Alejandro Seaman-Gómez
Jurhiat Alejandro Seaman-Gómez
SCSergio Contreras-Garduño
Sergio Contreras-Garduño
JSJosé Sifuentes-Osornio
José Sifuentes-Osornio
Background: Lack of adherence to international recommendations leads to worse outcomes. During the COVID-19 pandemic, the total number and proportion of hospitalized patients increased, consequently straining hospital care and hindering adherence. Aims: To evaluate adherence to clinical guidelines at our center, before, during, and shortly after the COVID-19 pandemic-induced hospital strain, and its association with clinical outcomes, using a random, balanced retrospective cohort. Design: A balanced and randomized sample of 50 patients per year between 2019 and 2022 was drawn from electronic medical records and analyzed with multivariable and logistic regression models. The primary outcome was a composite of in-hospital death, hemodynamic decompensation within the first 7 days, and in-hospital bleeding. Results: The global non-adherence in our study was 45.4%. The main risk factors for non-adherence were any mortality risk classification above low-risk PE and a PESI class different from class I, with ORs of 3.47 (95% CI 2.07–5.82) and 1.57 (95% CI 1.04–2.37), respectively. In both periods (COVID-19 season and non-COVID-19 season), non-adherent management strongly correlated with the composite outcome, OR = 2.36 (95% CI, 1.23–4.54). Non-adherence was also associated with worse in-hospital outcomes, with an incidence rate of the composite outcome of 21.08 per 1000 days/person (95% CI 10.97–40.51) and 47.7 per 1000 days/person (95% CI 33.39–67.50), and an attributable risk of 1.09% (95% CI −8.47%−10.64%). Conclusions: Overall, our findings highlight the need to prioritize human and material resources to ensure adherence to the standards of care for PE patients.

20 August 2025 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
CCCamila Castillo-Tello
Camila Castillo-Tello
CBClemente Barron-Magdaleno
Clemente Barron-Magdaleno
COConsuelo Orihuela-Sandoval
Consuelo Orihuela-Sandoval
EGEduardo Gutiérrez-León
Eduardo Gutiérrez-León
Background: Parkes Weber syndrome (PWS) is a rare congenital vascular syndrome characterized by complex capillary malformation , venous malformation, lymphatic malformation, and arteriovenous malformation (AVM) in the affected limb with overgrowth; the latter is a pathognomonic feature that differentiates it from Klippel–Trenaunay syndrome. Cardiovascular complications include increased cardiac output, which promotes the onset of heart failure and the development of pulmonary hypertension (PAH), significantly impairing the quality of life due to severe functional class deterioration. However, these complications are currently treatable by ligation or removal of malformations. Case report: A 33-year-old male with a long-standing, progressively enlarging AVM of the right upper limb presented with necrosis and haemorrhage, leading to hypovolemic shock. Angiography revealed an AVM involving the subclavian, axillary, and brachial arteries, necessitating embolization and surgical interventions. Six years later, he developed distal finger necrosis, requiring infracondylar amputation. He later presented with stump infection, purulent discharge, orthopnoea, jugular venous distension, a loud second heart sound, and a holosystolic murmur in the tricuspid region. Echocardiography and catheterization confirmed PAH and a high-flow arteriovenous fistula. Multidisciplinary evaluation led to definitive amputation and PAH treatment. Postoperatively, PAH resolved, and the patient was discharged with ongoing follow-up, showing significant improvement. Discussion: This case report highlights the importance of a multidisciplinary approach in managing PWS, especially when endovascular interventions are not feasible owing to the diffuse nature of the AVM. It also emphasizes the potential for reversing severe complications through definitive surgical intervention in complex cases of PWS.